Neurocrine director Leslie V. Norwalk sells 1,250 shares for $227,507.5

PUBT · 2d ago
Neurocrine director Leslie V. Norwalk sells 1,250 shares for $227,507.5
  • Neurocrine Biosciences director Leslie V. Norwalk sold 1,250 shares on July 28 at a weighted average price of USD 182.01.
  • Norwalk exercised a non-qualified stock option for 842 shares on July 29 at USD 139.43.
  • She reported 2,430 shares owned following the transactions.
  • She also reported 2,140 non-qualified stock options outstanding following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001533568-26-000012), on July 30, 2026, and is solely responsible for the information contained therein.